SLI
2.121,57
PKT
+32,74
PKT
+1,57
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 05.02.20 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 05.02.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 05.02.20 | UBS buy | Goldman Sachs Group Inc. | |
| 04.02.20 | Holcim overweight | JP Morgan Chase & Co. | |
| 04.02.20 | Roche buy | Deutsche Bank AG | |
| 04.02.20 | Givaudan buy | UBS AG | |
| 03.02.20 | Givaudan buy | UBS AG | |
| 03.02.20 | Roche overweight | JP Morgan Chase & Co. | |
| 03.02.20 | UBS overweight | JP Morgan Chase & Co. | |
| 03.02.20 | Zurich Insurance Hold | Deutsche Bank AG | |
| 31.01.20 | Roche Neutral | Credit Suisse Group | |
| 31.01.20 | Novartis Hold | Deutsche Bank AG | |
| 31.01.20 | Roche buy | Deutsche Bank AG | |
| 31.01.20 | Givaudan Underperform | Bernstein Research | |
| 30.01.20 | Novartis Neutral | Credit Suisse Group | |
| 30.01.20 | Roche overweight | Barclays Capital | |
| 30.01.20 | Roche buy | UBS AG | |
| 30.01.20 | Roche buy | Goldman Sachs Group Inc. | |
| 30.01.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 30.01.20 | Roche overweight | JP Morgan Chase & Co. | |
| 30.01.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 29.01.20 | UBS Underweight | Barclays Capital | |
| 29.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 29.01.20 | Novartis Neutral | UBS AG | |
| 29.01.20 | Novartis Hold | Kepler Cheuvreux | |
| 29.01.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 28.01.20 | UBS buy | Goldman Sachs Group Inc. | |
| 28.01.20 | UBS Outperform | Credit Suisse Group | |
| 28.01.20 | Nestlé kaufen | Kepler Cheuvreux | |
| 28.01.20 | Givaudan buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.01.20 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 27.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.01.20 | Roche buy | Goldman Sachs Group Inc. | |
| 27.01.20 | UBS Hold | Deutsche Bank AG | |
| 27.01.20 | Givaudan Hold | Deutsche Bank AG | |
| 27.01.20 | Roche buy | Deutsche Bank AG | |
| 24.01.20 | UBS Sector Perform | RBC Capital Markets | |
| 24.01.20 | Zurich Insurance buy | Goldman Sachs Group Inc. | |
| 24.01.20 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 24.01.20 | Givaudan buy | UBS AG |